Ergoteles’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-16,049
Closed -$685K 1276
2023
Q1
$685K Buy
+16,049
New +$685K 0.03% 630